Meet PSI, the CRO delivering

93% of studies on time industry-low 9% turnover rate a unique approach to site support 0% change orders due to underbidding 95% repeat and referral rate

3,200

Employees

93%

Studies On Time or
Ahead of Schedule

58

Countries

A full-service global CRO that will prioritize your study

PSI specializes in pivotal phase 2 and phase 3 clinical trials in oncology, hematology, gastroenterology, autoimmune, infectious diseases, neurology, and other indications. We provide expertise in complex trials at the forefront of precision medicine, including platform and umbrella designs, trials in targeted immunotherapy, radiopharmaceuticals, and cell and gene therapies.

93% of our studies enrolled on time or ahead of schedule in 2024, thanks in part to our proprietary machine-learning-enabled feasibility tool, VISIONAL™.  Along with our unique approach to site support, this results in faster study start-up and much more reliable patient enrollment. Sites around the world love working with us, which means your study stands out from the crowd. 

And it’s not just sites. Our sponsors enjoy working with PSI so much that we have a 95% repeat and referral business rate. 

If you’re ready for a CRO that puts your study first, complete the form to schedule a meeting.

"*" indicates required fields

Agreement*

Meet PSI, the CRO delivering

93% of studies industry-low 95% repeat

on time 9% turnover rate & referral rate

3,000+

Employees

93%

Studies On Time or
Ahead of Schedule

56

Countries

A full-service global CRO that will prioritize your study

PSI specializes in pivotal phase 2 and phase 3 clinical trials in oncology, hematology, gastroenterology, autoimmune, infectious diseases, neurology, and other indications. We provide expertise in complex trials at the forefront of precision medicine, including platform and umbrella designs, trials in targeted immunotherapy, radiopharmaceuticals, and cell and gene therapies.

93% of our studies enrolled on time or ahead of schedule in 2024, thanks in part to our proprietary machine-learning-enabled feasibility tool, VISIONAL™. Along with our unique approach to site support, this results in faster study start-up and much more reliable patient enrollment. Sites around the world love working with us, which means your study stands out from the crowd. 

And it’s not just sites. Our sponsors enjoy working with PSI so much that we have a 95% repeat and referral business rate. 

If you’re ready for a CRO that puts your study first, complete the form to schedule a meeting.

Get in Touch

"*" indicates required fields

Agreement*

PSI CRO Highlights

  • Full-service global CRO of over 3,000 employees in 56 countries 
  • Organically grown since 1995
  • 0% change orders due to underbidding 
  • Only fully independent and privately owned CRO of its size
  • Turnover rates lower than industry average (only 9% in 2024) 

PSI CRO Highlights

  • Full-service global CRO of over 3,000 employees in 56 countries 
  • Only fully independent and privately owned CRO of its size
  • Organically grown since 1995 
  • Turnover rates lower than industry average (only 9% in 2024)
  • 0% change orders due to underbidding 

About Us

> Learn More

Therapeutic Areas

> Learn More

Global Reach

> Learn More